Clin2
NCT07681154Possibly a fitNot yet recruiting

Catheter device for blood clots in the lungs

Pulmonary Embolism (PE)Pulmonary Embolism With Right Ventricle Enlargement

Part of Heart & circulation, Lungs & breathing clinical trials.

This trial tests a new catheter-based device to break up blood clots in the lungs for people with a moderate-risk pulmonary embolism (PE). The goal is to see if it can improve blood flow and reduce strain on the heart.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have been diagnosed with a blood clot in your lungs (pulmonary embolism) within the last 14 days.
  • Your heart is under strain from the clot (shown on a CT scan).
  • You are healthy enough to receive standard blood thinners and the catheter procedure.
  • You do not have other serious medical conditions like uncontrolled bleeding, recent stroke, severe high blood pressure, or kidney problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07452991Recruiting
Ultrasound-guided clot-busting for moderate-risk pulmonary embolism

This trial tests a procedure that uses ultrasound to guide a catheter that delivers clot-dissolving medicine directly to a blood clot in the lungs. It is for people who have a pulmonary embolism that causes some heart strain but who are not in shock.

Moscow
NCT06672510Recruiting
Study of a clot-removal device for acute pulmonary embolism

This trial tests a new device that removes blood clots from the lungs through a small tube. It is for people with a recent pulmonary embolism who have slightly strained hearts but stable blood pressure.

Thousand Oaks, California
NCT06487052Recruiting
Catheter-based clot-dissolving drug for intermediate-high risk pulmonary embolism

This trial tests whether a standard procedure using a catheter to deliver clot-dissolving medicine directly into the lung artery works well for people with a serious but not immediately life-threatening blood clot in the lungs (pulmonary embolism). It aims to improve heart function and reduce long-term complications.

Saint Petersburg
NCT05591118Recruiting· Phase 3
Catheter treatment to remove blood clots in the lungs

This Phase 3 trial tests a catheter-based procedure to remove a lung blood clot (pulmonary embolism) and reduce strain on the heart. It may help people who have specific CT scan signs of right-heart strain.

Birmingham, Alabama
NCT05821426Not yet recruiting
Clot removal device test for acute pulmonary embolism

This trial studies a clot-removal device used through a catheter to treat acute pulmonary embolism (a blood clot in the lungs). It aims to see if the device can safely remove clots and improve outcomes compared with standard care planning.

NCT06348459Recruiting
Catheter treatment for severe pulmonary embolism

This study looks at how well a catheter (a thin tube) works to treat a serious type of blood clot in the lungs. It is for people who have a large clot that is causing problems like fast heart rate or low blood pressure.

Madrid, Madrid

Hear when a new Pulmonary Embolism (PE) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.